Bellevue F.(L)-B.Obesity Sol.B USD/  LU0415392322  /

Fonds
NAV2024-04-25 Chg.-0.8500 Type of yield Investment Focus Investment company
501.4600USD -0.17% reinvestment Equity Waystone M.Co.(Lux) 
     
Chart for Bellevue F.(L)-B.Obesity Sol.B USD
  Name   ISIN Performance Volatility Sharpe ratio
1. BIT Biotech Opportunities S DE000A3DCA95 +41.60% 33.39% 1.13
2. Biotech Core Mid-Cap Fund LI0237235184 +20.01% 23.11% 0.70
3. F.Biotechnology Dis.Fd.A SGD LU0320765992 +15.24% 17.71% 0.64
4. F.Biotechnology Dis.Fd.Z GBP LU0774687577 +13.04% 17.93% 0.51
5. J.Henderson H.BioTech.F.IU2 LU2441282626 +20.81% 20.66% 0.82
6. F.Biotechnology Dis.Fd.I USD LU0195948822 +14.44% 18.75% 0.56
7. F.Biotechnology Dis.Fd.W USD LU0976566496 +14.40% 18.79% 0.56
8. Abaris Biotech.Opportunities A EUR LU2210105669 +25.53% 37.90% 0.57
9. J.Henderson H.BioTech.F.A2 LU2441282899 +20.68% 20.59% 0.82
10. F.Biotechnology Dis.Fd.Z USD LU1446800499 +14.03% 18.77% 0.54
...
81. Bellevue F.(L)-B.Obesity Sol.B USD LU0415392322 -5.17% 12.93% -0.70